Studies have found that these FIBG-containing EVs can activate the activity of NLRP3 inflammasomes and induce lymphocyte aggregation, consistent with the characteristics of inflammation-carcinogenesis during the process of CRC development. This evidence concerns the gene NLRP3 and colorectal carcinoma.